Physician

Ai Ngoc Tran, M.D.

According to 2025 Medicare claims, Ai Tran, M.D. (NPI: 1316149412) practices nephrology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Campbell, KY. This provider's primary affiliated billing organization is KIDNEY ASSOCIATES OF THE TRISTATE (NPI: 1831730183; TIN: 84-3046513) and primary practice location at 41017-3403. Tran is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 425 traditional Medicare patients, billed 2,295 HCPCS/CPT codes, and received $221,877 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,212 prescription claims across 368 beneficiaries totaling $128,582 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 88 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $116,060 to $128,582. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $800 to $228.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	397	2,148	$168,966
2016	425	2,067	$158,390
2017	446	2,126	$160,282
2018	562	2,968	$244,774
2019	526	3,003	$267,455
2020	514	3,648	$297,853
2021	492	3,438	$321,738
2022	446	3,074	$285,935
2023	438	2,392	$246,215
2024	425	2,295	$221,877

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	276	2,389	$116,060
2016	302	2,984	$296,415
2017	294	3,073	$264,040
2018	312	2,615	$267,622
2019	319	2,116	$239,309
2020	290	1,975	$199,392
2021	313	2,059	$167,116
2022	316	2,090	$181,870
2023	339	2,102	$151,364
2024	368	2,212	$128,582

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$702
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	28	$798
2023	N/R	80	$1,542
2024	N/R	88	$1,358

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	144	203	$128
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	60	105	$121
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	193	1,137	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	162	192	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	93	436	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	23	1,332	$33,834
Sevelamer Carbonate	Sevelamer Carbonate	12	773	$2,468
Nifedipine Er	Nifedipine	88	7,080	$2,334
Potassium Citrate Er	Potassium Citrate	30	1,058	$2,045
Candesartan Cilexetil	Candesartan Cilexetil	14	1,200	$1,239

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	17	$464
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	24	$433
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	24	$288
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	23	$173

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ai Ngoc Tran, M.D.?

Tedicare shows public-source Medicare data for Ai Ngoc Tran, M.D. (NPI 1316149412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ai Ngoc Tran, M.D. have ACO affiliation data?

Ai Ngoc Tran, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Ai Ngoc Tran, M.D.?

Ai Ngoc Tran, M.D. is linked to KIDNEY ASSOCIATES OF THE TRISTATE (billing NPI 1831730183) in the available physician profile data.

Does Ai Ngoc Tran, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.